As of January 2026 EyePoint Pharmaceuticals has a market cap of $1.34 Billion USD. This makes EyePoint Pharmaceuticals the world's 5475th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 9th, 2026 the market cap of EyePoint Pharmaceuticals was reported to be: